Position in DHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$428,580
+$13,167 QoQ
Shares Held
2,250
+2.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,442
of 2,092 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FOSTER DYKEMA CABOT & PARTNERS, LLC holds $22,172,503 across 7 Diagnostics & Research names. DHR ranks #3 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
41,685 | $20,899,191 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
895 | $471,163 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
2,250 | $428,580 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,320 | $175,335 | |
| 5 | WAT |
Waters Corp /De/
|
352 | $132,014 | |
| 6 | LH |
Labcorp Holdings Inc.
|
127 | $35,560 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
24 | $30,660 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $428,580 | 2,250 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $415,413 | 2,191 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $511,636 | 2,235 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $451,041 | 2,275 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $449,403 | 2,275 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $488,515 | 2,383 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $817,427 | 3,561 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $757,604 | 2,725 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $406,505 | 1,627 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $225,247 | 902 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $208,668 | 902 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||